tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kyle Boucher, 3 are a BUY (60%), 2 are a HOLD (40%).
Analyst Kyle Boucher, currently employed at TD COWEN, carries an average stock price target met ratio of 66.67% that have a potential upside of 30.92% achieved within 76 days.
Kyle Boucher’s has documented 10 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MYGN, Myriad Genetics at 30-Jul-2026.
Analyst best performing recommendations are on MYGN (MYRIAD GENETICS).
The best stock recommendation documented was for MYGN (MYRIAD GENETICS) at 7/31/2026. The price target of $4 was fulfilled within 48 days with a profit of $1.14 (39.86%) receiving and performance score of 8.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Aug-2025
$2.5
1 years 1 months 22 days ago
(13-Aug-2025)
1/5 (20%)
$0.54 (27.55%)
4
Hold Since 27-Feb-2025
$4
1 years 7 months 8 days ago
(27-Feb-2025)
1/2 (50%)
$1.63 (68.78%)
93
Buy Since 13-Mar-2019
$10
$8.87 (784.96%)
$12
4 years 9 months 19 days ago
(16-Dec-2021)
0/5 (0%)
$6.21 (163.85%)
Buy Since 07-Aug-2020
$7
$5.87 (519.47%)
$8
5 years 4 months 23 days ago
(12-May-2021)
1/5 (20%)
$1.82 (35.14%)
77
Buy Since 02-Nov-2018
$9
$7.87 (696.46%)
$14
6 years 7 months 24 days ago
(11-Feb-2020)
3/9 (33.33%)
$5.22 (138.10%)
103
Which stock is Kyle Boucher most bullish on?
Which stock is Kyle Boucher most reserved on?
What Year was the first public recommendation made by Kyle Boucher?
